# A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

> **NCT00888381** · PHASE4 · COMPLETED · sponsor: **Seqirus** · enrollment: 120 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Inactivated Influenza Vaccine (2009 / 2010 formulation)

## Key facts

- **NCT ID:** NCT00888381
- **Lead sponsor:** Seqirus
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-06-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00888381

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00888381, "A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00888381. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*